Skip to main content

Table 2 Proportion of ART facilities that meet WHO EWI targets, aggregated by programmatic characteristics, Tanzania, 2010

From: Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania

Programatic characteristics

HIVDR early warning indicators (EWIs)

  

EWI 1a, ART prescribing practices

EWI 2, patients LTFU at 12 months

EWI 3a, retention on 1st line ART at 12 months

EWI 5b, clinic appointment keeping in first 12 months

  

WHO target: 100%

WHO target: ≤ 20%

WHO target: ≥ 70%

WHO target: ≥ 80%

 

Frequency

n (%)

n (%)

n (%)

n (%)

National average performance on EWIs

(N = 35)

35 (100)

17 (49)

10 (29)

1 (3)

Facility administrative level

  Referral hospitals

4

4 (100)

2 (50)

0 (0)

1 (25)

  Non-referral hospitals

17

17 (100)

7 (41)

5 (29)

0 (0)

  Health centers

14

14 (100)

8 (57)

5 (36)

0 (0)

   

p = 0.793

p = 0.512

p = 0.114

Facility locality

  Urban

20

20 (100)

11 (55)

5 (25)

1 (5)

  Semi-urban

6

6 (100)

2 (33)

1 (17)

0 (0)

  Rural

9

9 (100)

4 (44)

4 (44)

0 (0)

   

p = 0.727

p = 0.582

p = 1.000

Facility ownership type

  Public

28

28 (100)

13 (46)

8 (29)

0 (0)

  Faith-based

7

7 (100)

4 (57)

2 (29)

1 (14)

   

p = 0.691

p = 1.000

p = 0.200

Facility maturity (years providing ART services)

  > 5

6

6 (100)

4 (67)

2 (33)

1 (17)

  3-5

15

15 (100)

5 (33)

3 (20)

0 (0)

  < 3

14

14 (100)

8 (57)

5 (36)

0 (0)

   

p = 0.324

p = 0.611

p = 0.171

  1. EWI 1a, % of adult patients initiating ART at the site who are initially prescribed, or who initially pick up from the pharmacy, an appropriate first-line ART regimen.
  2. EWI 2, % of patients initiating ART at the site who are lost to follow-up (LTFU) 12 months after ART initiation.
  3. EWI 3a, % of adult patients initiating ART at the site who are taking an appropriate first-line ART regimen 12 months later.
  4. EWI 5b, % of patients initiating ART at the site who attended all scheduled or expected clinical consultations on time during the first 12 months.